Clinical Trial Update: Subclinical Cardiovascular Disease in Psoriatic Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on subclinical cardiovascular disease in psoriatic disease; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Cardiovascular Diseases
• Myocardial Infarction
• Thrombotic Vascular Disease

Snippet

Sponsor: NYU Langone Health | Conditions: Cardiovascular Diseases, Myocardial Infarction | Phase 4 | Status: COMPLETED | Results posted: 2021-09-28